Dar’jA Vladimirovna Sidorenko

Dar’jA Vladimirovna Sidorenko

Auto-generated profile, based on publicly available information

Dar’jA Vladimirovna Sidorenko

Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2022 in Russian Clinical Laboratory Diagnostics
Verified
Journal Article
Open access
DSDar’jA Vladimirovna Sidorenko
Dar’jA Vladimirovna Sidorenko
VNVladimir Nazarov
Vladimir Nazarov
EVE. G. Volnikova
E. G. Volnikova
EKE. A. Kondrasheva
E. A. Kondrasheva
NPN. G. Peshkova
N. G. Peshkova
SLSergey V. Lapin
Sergey V. Lapin
Diagnosis of Gilbert’s syndrome is based on the detection of homozygous carriage of an additional TA-repeat in the promoter of the UGT1A1 gene, leading to a decrease in the activity of the UGT enzyme. No large studies have been done in the Russian Federation on the prevalence of carriage of Gilbert’s syndrome, as well as the biochemical and molecular profile of such patients. The aim of the study is to evaluate biochemical and molecular genetic parameters in patients with Gilbert’s syndrome in Russia. The study included 124 healthy volunteers (group 1) and 5650 patients with suspected Gilbert’s syndrome (group 2). The number of TA-repeats of the promoter region of the UGT1A1 gene was determined by the method of fragment analysis for all participants. The following biochemical parameters were analyzed for 299 patients from group 2: the level of bilirubin and its fractions, AST, ALT, cholesterol and LDL. In group 1 the prevalence of genotype (TA)6/(TA)6 was 39,52%, (TA)6/(TA)7 - 53,23%, (TA)7/(TA)7 - 7,26%, no rare forms were found. In group 2 the prevalence of genotype (TA)6/(TA)6 was 6,04%, (TA)6/(TA)7 - 20,05%, (TA)7/(TA)7 - 73,7%, rare alleles - 0,2%. Rare alleles included (TA)5/(TA)6, (TA)5/(TA)7, (TA)6/(TA)8 and (TA)7/(TA)8, as well as a new genotype not described in the literature previously - (TA)7/(TA)9. When assessing the level of total bilirubin and its fractions, a difference was revealed between the genotype of Gilbert’s syndrome (TA)7/(TA)7 and the reference genotype (TA)6/(TA)6, and between genotypes (TA)7/(TA)7 and (TA)6/(TA)7. A significant increase in total bilirubin was demonstrated in carriers of a larger number of TA-repeats. There was no significant difference in the concentration of ALT, AST, cholesterol or LDL between different genotypes.The number of TA-repeats of the UGT1A1 gene affects the increase of total bilirubin and its indirect fraction, including the cases of rare allelic variants (TA≤5, TA≥8), but not the activity of ALT and AST and the lipid profile.

21 September 2022 in Neuromuscular Diseases
Verified
Journal Article
Open access
PDF file
АДА. В. Диль
А. В. Диль
VNVladimir Nazarov
Vladimir Nazarov
DSD. V. Sidorenko
D. V. Sidorenko
SLSergey V. Lapin
Sergey V. Lapin
ВЭВ. Л. Эмануэль
В. Л. Эмануэль
Background. Proximal spinal muscular atrophy 5q (5q‑SMA) is one of the most common neuromuscular diseases, which is caused by mutations of the SMN1 gene. Despite the fact that most studies consider SMN1 “deletion” as the most common cause of 5q‑SMA, gene loss is in fact associated with both classical deletions and conversions of SMN1 and SMN2, as well as with formation of chimeric structures. Up to now, far too little attention has been paid to the prevalence of types of SMN1 loss. However, different types of mutations can have different influence on the clinical findings and the effectiveness of therapy. A deeper study of the structure of these genes will allow us to determine the predictors of response to treatment and bring us closer to understanding the reasons for the instability of the SMN region.Aim. To study genetic changes in the SMN1 gene, as well as the number of copies of the SMN1 and SMN2 genes in 5q‑SMA.Materials and methods. The study involved 703 patients, for whom the analysis of the number of copies of SMN1 and SMN2 was performed in the center of molecular medicine of I.P. Pavlov First Saint Petersburg State Medical University for 2018–2021. Gene copy number analysis was performed by multiplex ligation‑dependent probe amplification (MLPA) using the SALSA MLPA P021 SMA kit (MRC Holland).Results. Among 703 participants, a homozygous SMN1 deletion was found in 167 (24 %), 76 (11 %) were carriers of the deletion and no aberrations were found in the remaining 460 (65 %). Among patients with a homozygous deletion, 41 (24 %) cases of a true deletion were identified. Also, 11 (7 %) cases of partial deletion with a homozygous loss of the 7th exon and heterozygous of the 8th exon of SMN1 were identified. The most common type of aberration was the conversion of SMN1 to SMN2 – 94 (56 %) cases, which is characterized by a homozygous loss of SMN1 and a reciprocal increase in SMN2 copies. In addition, 21 (13 %) cases of the formation of hybrid genes were found.Conclusion. Types of genetic aberrations in 5q‑SMA have not been studied enough yet. A search of the literature revealed very few studies which results are comparable with ours. However, further research of genetic changes in SMN1 and SMN2 might bring more clarity on the causes and mechanisms of this disease, and get us closer to finding the most effective method of treatment.

14 May 2023 in Russian Journal of Oncology
Verified
Journal Article
Open access
PDF file
AMAnastasia K. Musonova
Anastasia K. Musonova
VNVladimir Nazarov
Vladimir Nazarov
DSDaria V. Sidorenko
Daria V. Sidorenko
AMAram Ashotovich Musaelyan
Aram Ashotovich Musaelyan
EAEkaterina A. Alekseeva
Ekaterina A. Alekseeva
VEVladimir L. Emanuel
Vladimir L. Emanuel
INTRODUCTION: Anaplastic thyroid carcinoma (ATC) is the most aggressive type of thyroid cancer accounting for 12% of all malignancies. Systemic therapy remains the main treatment strategy. Targeted therapy and immunotherapy are prescribed when certain molecular genetic aberrations are detected. THE AIM: To investigate the molecular genetic profile of samples of anaplastic thyroid carcinoma. MATERIALS AND METHODS: The study included 37 patients with ATC. Mutation V600E BRAF, mutations in the gene NRAS and KRAS were detected by allele-specific polymerase chain reaction (AS-PCR). Microsatellite instability (MSI) was determined by fragment analysis in according to ESMO recommendations. Mutations in the promoter region of the TERT gene were used by Sanger sequencing. NTRK1, EML4-ALK, PAX8/PPARy и RET/PTC translocations were determined in all patients with ATC by real-time polymerase chain reaction (PCR). RESULTS: According to the results of the study, the frequency of the V600E mutation in the BRAF gene was 32.4% (12/37). The frequency of aberrations in the NRAS, KRAS genes in anaplastic thyroid carcinoma was 13.5% (n=5). The prevalence of point mutations in the promoter gene TERT in food samples of ATC was 24.3% (n=9). MSI was found in 2.7% (1/37) of cases of anapalastic thyroid carcinoma. NTRK1, EML4-ALK, PAX8/PPARy and RET/PTC translocations were not detected in cases with anaplastic thyroid carcinoma. CONCLUSION: The further study of the main specific molecular targets in cancer cells will allow to personalize the tactics of patients with anaplastic thyroid carcinoma.

4 September 2024 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
VGV. P. Gomonova
V. P. Gomonova
KRK. L. Raikhelson
K. L. Raikhelson
EPE. V. Pazenko
E. V. Pazenko
MPM. K. Prashnova
M. K. Prashnova
SLSergey V. Lapin
Sergey V. Lapin
DSD. V. Sidorenko
D. V. Sidorenko
Aim. Тo study cardiometabolic factors and the PNPLA3 I148M (rs738409 C>G) gene polymorphism in association with the compensated advanced chronic liver disease (cACLD) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Materials and methods. А retrospective cross-sectional study was conducted. The total of 108 patients with MASLD (33 men and 75 women aged 28 to 89 years) involved were divided into two groups based on results of transient elastography: group 1 – with the presence of cACLD (liver stiffness ≥ 8.0 kPa) – 18 patients and group 2 – without cACLD (G) gene polymorphism were studied in both groups. Odds ratios (OR) and 95% confidence intervals (CI) were calculated, and a logistic regression model was constructed for the detection of cACLD.Results. Compared to group 2, patients with cACLD had statistically significant higher prevalence of: arterial hypertension (p < 0.05), type 2 diabetes mellitus (p < 0.01), obesity (p < 0.05), dyslipidemia (p < 0.05), and PNPLA3 gene polymorphism (p < 0.05). The OR for cACLD in individuals with arterial hypertension was 5.58 (95% CI: 1.21–25.71; p < 0.05), with type 2 diabetes mellitus – 4.58 (95% CI: 1.59–13.21; p < 0.01), with obesity – 3.83 (95% CI: 1.17–12.52; p < 0.05), with dyslipidemia – 6.12 (95% CI: 1.33–28.20; p < 0.05), in the presence of a polymorphic variant of the PNPLA3 gene in a hetero or homozygous state – 3.9 (95% CI: 1.28–11.89; p < 0.05). The binary logistic regression model for detecting cACLD included type 2 diabetes mellitus, dyslipidemia, and waist circumference. The area under the ROC curve was 0.81 (95% CI: 0.70–0.92), sensitivity was 72.2%, specificity was 74.4%, and accuracy was 84.3%.Conclusion. Type 2 diabetes mellitus, dyslipidemia, and waist circumference are the determining factors for the development of cACLD in patients with MASLD. The PNPLA3 I148M gene polymorphism does not play a leading role in the development of progressive MASLD in the study cohort.

24 December 2025 in Neuromuscular Diseases
Verified
Journal Article
Open access
PDF file
EVElizaveta V. Vuta
Elizaveta V. Vuta
VNVladimir Nazarov
Vladimir Nazarov
DSD. V. Sidorenko
D. V. Sidorenko
DBD. Yu. Banina
D. Yu. Banina
SLSergey V. Lapin
Sergey V. Lapin
Alexandra MazingAlexandra Mazing
Alexandra Mazing
Background. Expansion-based autosomal dominant spinocerebellar ataxias (ADSСA-E) represent a clinically and genetically heterogeneous group of inherited neurodegenerative disorders characterized by cerebellar atrophy. According to global population data, they account for approximately 61 % of all autosomal dominant spinocerebellar ataxias. The number of nucleotide repeats is a key determinant of penetrance, expressivity, and age of onset, necessitating precise molecular genetic analysis. Significant differences in the structure of ADSСA-E across populations underscore the need for regional studies. Aim. Analysis of the molecular structure and frequency of ADSCA-E in a sample of Russian patients with cerebellar ataxias. Materials and methods. DNA samples from 1272 patients with clinical signs of ataxia (2017–2024) were analyzed. The number of repeats in the ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP, ATXN10, PPP2R2B, NOP56, and ATXN8OS genes was determined using fluorescent polymerase chain reaction and fragment analysis. The age at referral to the laboratory was considered an indirect marker of disease aggressiveness. Statistical analysis was performed using GraphPad Prism 10. Differences were considered statistically significant at p 0.05. Pearson’ correlation coefficient was used to calculate correlation. Results. A pathological expansion was identified in 102 (8 %) patients. The most frequent form was spinocerebellar ataxia (SCA) type 1 (62.7 %), followed by SCA type 2 (17.6 %), SCA type 3 (5.9 %), and SCA type 6 (3.9 %); other types were rare. A case of combined SCA type 1 and SCA type 8 mutations was recorded in one patient. For SCA type 1 and SCA type 2, a significant negative correlation was established between the expansion size and the age at referral (p 0.0001; r = –0.6839 and –0.8838, respectively). Conclusion. Data on the frequency and spectrum of ADSCA-E in the Russian Federation, including rare forms, were obtained. The prognostic significance of the repeat number was confirmed, and the necessity of molecular genetic testing, taking into account regional disease prevalence patterns, was emphasized.

20 January 2025 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
AKA. G. Khachaturian
A. G. Khachaturian
VNVladimir Nazarov
Vladimir Nazarov
IDI. A. Dubina
I. A. Dubina
SLSergey V. Lapin
Sergey V. Lapin
DSD. V. Sidorenko
D. V. Sidorenko
ВЭВ. Л. Эмануэль
В. Л. Эмануэль
Beta-thalassemia being one of the most widespread monogenic diseases in the world is characterized by the HBB gene mutations leading to beta-globin chain decrease. Despite of the specific laboratory features diagnosis of beta-thalassemia may seem difficult especially when speaking of minor forms and carriers. The common diagnostic standard includes complete blood count with analysis of hematological indices, iron deficiency exclusion and examination of hemoglobin fractions. The last and the crucial step is providing molecular-genetic study of HBB gene as the method allowing to verify the diagnosis. The beta-thalassemia pathogenesis, comprehensive genetic classification and various laboratory diagnostics tools are discussed in this review. There exists huge knowledge about beta-thalassemia prevalence in endemic regions but little is known of beta-thalassemia incidence in nonendemic countries, e.g., Russian Federation. Nevertheless, studying beta-thalassemia prevalence in Russia remains relevant considering multi ethnicity of Russian Federation. This review presents the diagnostics algorithm with the use of HBB gene Sanger sequencing and the results of beta-thalassemia prevalence pilot research. According to the data obtained the minimal possible beta-thalassemia incidence in Moscow accounts for 0.16 %.